“…A biomarker can thus provide impartial information regarding the current physiological state of living organisms (Gill et al, 2017). Biomarkers exist in the form of antibodies (Dardari et al, 2000: IgG-ZEBRA as a biomarker in young patients with nasopharyngeal carcinoma), microbes (Shah et al, 2018: the fecal microbiome as a biomarker of colorectal cancer), DNA (Teo et al, 2019: sequencing of circulating cell-free DNA [cfDNA] from human blood plasma as a noninvasive methodology to study age-associated changes in the epigenome in vivo), RNA/miRNA (as tabulated in this review), lipids (Seow et al, 2019: the lipid fraction of the solid nonenhancing region showed potential as a novel prognostic biomarker of survival outcome in glioma), metabolites [Lou et al, 2019: a urinary metabolite of polycyclic aromatic hydrocarbons, 8hydroxy-2′-deoxyguanosine (8-OHdG), can be a biomarker of oxidative stress in pregnant women], and/or protein [Xu et al, 2019: serum protein, the insulin-like growth factor-binding protein miR-19, miR-21, miR-132, miR-133, miR-146, miR-155, miR-223, miR-377, miR-451, miR-641, miR-887, miR-1246, and miR-4284 CAD miRNAs were associated with MP-containing plasma compared to MP-free plasma of CAD patients Tabet et al, 2016 HDL -serum PEG-6000 method Qiazol miRNA-easy kits f Weight loss Downregulation in HP patient vs. normal protein diet miR-16 and According to previous study: downregulation in gastric bypass bariatric surgery patients -548c-5p, miR-638, miR-5787, miR-8975, and miR-6869-5p Involved in the process of glucose metabolism in CRC Ostenfeld et al, 2016 Pooled (IGFBP-1), as a biomarker for the early detection of gastrointestinal cancer]. Alteration in biomarker concentration, structure, function, or action can be associated with the onset, progression, or even regression of a particular disorder as a result of how the body responds to it (Gill et al, 2017).…”